Roundtable Discussion: Navigating Common but Critical Challenges Associated with LNPs to Build a Robust Toolkit for Developing Safe, Stable & Consistent LNPs

• Tackling common safety challenges of LNPs to enable redosability for more effective therapies
• Discussing the causes and impact of batch-to-batch variability and gaining insights into practical approaches for improving consistency
• Evaluating best practices for improving LNP stability and formulation to ensure global availability

Speakers:

Roger Adami

Chief Technology Officer

Land Therapeutics